FDA's hormone therapy warning rollback sparks estrogen patch shortage

The FDA's decision to rollback 'black box warnings' on hormone replacement therapy (HRT) in November 2025 has created an estrogen patch shortage. Dr. Janette Nesheiwat explains HRT's crucial benefits for millions of menopausal women and concerns about access to vital medication for hot flashes and bone loss.

NEW You can now listen to Fox News articles!

Polycystic-ovarian syndrome (PCOS) – a common women’s hormonal condition – has been renamed to polyendocrine metabolic ovarian syndrome (PMOS).

The revised name was introduced in a paper penned by women’s health experts from around the globe, which was then published in The Lancet medical journal.…